1p19q codeletion
Showing 1 - 25 of >10,000
Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion Trial in France (PCV chemo, Radiotherapy and PCV chemo)
Recruiting
- Oligodendroglioma
- +2 more
- PCV chemotherapy
- Radiotherapy and PCV chemotherapy
-
Amiens, France
- +25 more
Jun 14, 2022
Glioma Trial in Paris (MRI)
Not yet recruiting
- Glioma
- MRI
-
Paris, FrancePitié-Salpetrière Hospital
Jan 27, 2023
Glioma Grading and Genotyping
Recruiting
- Glioma
-
Chongqing, Chongqing, ChinaSang Zifan
Aug 29, 2023
People Who Have Genetic Changes and Features of Autism: Simons
Recruiting
- 16P11.2 Deletion Syndrome
- +184 more
-
New York, New York
- +1 more
Jan 6, 2023
COVID-19 Prevention Trial in Louisville (Q-Griffithsin 3.0, Q-Griffithsin 6.0)
Recruiting
- COVID-19 Prevention
- Q-Griffithsin 3.0
- Q-Griffithsin 6.0
-
Louisville, KentuckyUniversity of Louisville Clinical Trials Unit
Jun 28, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Laboratory Biomarker Analysis
- +3 more
-
Chicago, Illinois
- +2 more
Jan 12, 2023
COVID-19, Pharmacokinetics, Safety Trial in Pittsburgh (Q-Griffithsin, Placebo)
Recruiting
- COVID-19
- +2 more
- Q-Griffithsin
- Placebo
-
Pittsburgh, PennsylvaniaIngrid Macio
Mar 31, 2022
COVID-19 Prevention Trial in Louisville (Q-Griffithsin, Placebo)
Completed
- COVID-19 Prevention
- Q-Griffithsin
- Placebo
-
Louisville, KentuckyUniversity of Louisville
Apr 28, 2022
Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma Trial in United States (P-CD19CD20-ALLO1, Rimiducid)
Not yet recruiting
- Diffuse Large B Cell Lymphoma
- +5 more
- P-CD19CD20-ALLO1
- Rimiducid
-
La Jolla, California
- +7 more
Aug 25, 2023
How do Perceptions of Coronavirus Disease Risk Influence Health
Recruiting
- Pregnancy Related
-
Vancouver, British Columbia, Canada
- +1 more
Jan 9, 2023
DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid
Completed
- Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
- +8 more
- Laboratory Biomarker Analysis
-
Philadelphia, PennsylvaniaChildrens Oncology Group
Jul 12, 2022
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +13 more
- Sirolimus
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 2, 2023
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Completed
- Adult Acute Megakaryoblastic Leukemia (M7)
- +15 more
- trebananib
- +3 more
-
Buffalo, New York
- +1 more
Sep 8, 2022
Antipsychotic Induced Weight Gain, Non-alcoholic Steatohepatitis (NASH) Trial in Miami (Miricorilant, Fluvoxamine)
Recruiting
- Antipsychotic Induced Weight Gain
- Non-alcoholic Steatohepatitis (NASH)
-
Miami, FloridaSite 01
Feb 3, 2023
COVID-19 Trial in Herston (UQSC2 Vaccine, NVX-CoV2373 vaccine)
Not yet recruiting
- COVID-19
- UQSC2 Vaccine
- NVX-CoV2373 vaccine
-
Herston, Queensland, AustraliaQ-Pharm Pty Ltd (Nucleus Network Brisbane)
Mar 8, 2023
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,
Terminated
- Adult Acute Basophilic Leukemia
- +16 more
- eltrombopag olamine
- standard follow-up care
-
Atlanta, Georgia
- +1 more
Jul 20, 2022
Smith-Magenis Syndrome Trial in Bron (Assessment)
Recruiting
- Smith-Magenis Syndrome
- Assessment
-
Bron, France
- +1 more
Oct 21, 2022
Hepatitis C, Chronic Trial in Taiwan (PEGASYS 180 µg Q1W, P1101 180 µg Q1W, 48 doses, P1101 270µg Q1W, 48 doses)
Completed
- Hepatitis C, Chronic
- PEGASYS 180 µg Q1W
- +3 more
-
Changhua, Taiwan
- +12 more
Oct 7, 2021
s on Preventative Primary Care--a Longitudinal Evaluation of
Recruiting
- Diabetes Mellitus
- +6 more
- Pre-pandemic time period (Jun 22, 2018 to March 12, 2020)
- Peri-pandemic time period (March 13, 2020 to December 3, 2021)
-
Hamilton, Ontario, CanadaMcMaster University Department of Family Medicine
Apr 12, 2023
Healthy Trial in Nottingham (BI 685509 oral formulation prototypes, BI 685509 standard oral formulation)
Completed
- Healthy
- R1: Reference Product X
- +12 more
-
Nottingham, United KingdomQuotient Sciences
Dec 7, 2022
NSCLC Trial in Jinan (DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin))
Recruiting
- Non-small Cell Lung Cancer
- DZD9008 and Probe drugs (midazolam, digoxin, rosuvastatin)
-
Jinan, Shandong, ChinaShandong Cancer Hospital (Shandong Provincial Institute of Cance
Jun 22, 2023
Anorexia Nervosa Trial in Canada (Virtual Family-Based Treatment)
Completed
- Anorexia Nervosa
- Virtual Family-Based Treatment
-
Newmarket, Ontario, Canada
- +3 more
Sep 6, 2022
Long-Term Development of Muscular Dystrophy Outcome Assessments
Not yet recruiting
- LGMD1A
- +33 more
-
Richmond, VirginiaVirginia Commonwealth University
Aug 3, 2023